TauroPharm

TauroPharm We develop antimicrobial lock solutions for patients with central-venous catheters. Improving the patient’s quality of life remains our number-one priority.

Founded in 2000, TauroPharm GmbH is a German company specialising in medical devices with antimicrobial efficacy. As TauroLock™ solutions have been approved in expert guidelines, we continue to expand our international network. Our mission
TauroPharm aims to make the application of vascular access devices (VAD) easier and safer. We are developing more effective ways to prevent catheter-associate

d complications – ranging from blood clotting to fatal infections. Our products
We have created a range of lock solutions suitable for implanted central-venous catheters (CVC) and port systems. These products contain several ingredients to prevent catheter occlusion and catheter-related infections. Today, TauroLock™ solutions are recommended in interdisciplinary guidelines on a national and international scale. These include the ESPEN (European Society for Clinical Nutrition and Metabolism), GAVeCeLT (Italian association for long-term central-venous access devices), SFNCM (French Society of Clinical Nutrition and Metabolism), and DGfN (German Society of Nephrology). All TauroLock™ products have been investigated in clinical trials and are certified by regulatory bodies. Our sales network
As a manufacturer, TauroPharm focuses on four areas: product development, production, training, and quality management. To distribute our products, we collaborate with international partners who provide support and advice to customers in their respective countries. Our correspondents have been carefully selected and hold trust-based partnerships with healthcare professionals in nephrology, oncology, gastroenterology, intensive and palliative medicine, and home care. Our educational programmes
TauroPharm offers special training in all countries where TauroLock™ products are sold and implemented. These programmes help distributors familiarise themselves with our lock solutions and their application.

Ready to go at the Renal Society of Australasia Conference in Christchurch! We've got more than one solution to prevent ...
17/06/2026

Ready to go at the Renal Society of Australasia Conference in Christchurch!

We've got more than one solution to prevent catheter-related complications in haemodialysis.

Stand no. 4, Wednesday through Friday!

Team TauroLock™ is heading Down Under! Together with our partners from Prima MediPharm, we’ll be attending the Renal Soc...
11/06/2026

Team TauroLock™ is heading Down Under!

Together with our partners from Prima MediPharm, we’ll be attending the Renal Society of Australasia (RSA) Conference in Christchurch.

If you’d like to have a chat about the prevention of catheter-related complications in haemodialysis, you can find us at stand no. 4 from 17 to 19 June.

Some more highlights from Glasgow: The ERA Congress was quite the international affair. We had partners from no less tha...
08/06/2026

Some more highlights from Glasgow: The ERA Congress was quite the international affair.

We had partners from no less than 16 countries supporting us on site:

Austria, Belgium, Czechia, Denmark, Egypt, France, Greece, Ireland, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden, Switzerland, UK.

Saving lives with locked lines in dialysis, all over the world.

Keeping busy and in great spirits in Glasgow with the European Renal Association (ERA).There’s still time to meet us and...
05/06/2026

Keeping busy and in great spirits in Glasgow with the European Renal Association (ERA).

There’s still time to meet us and our partners at booth 260. Come by if you can!

Next stop: Glasgow.Team TauroLock™ will be travelling to Scotland for the 63rd Congress of the European Renal Associatio...
28/05/2026

Next stop: Glasgow.

Team TauroLock™ will be travelling to Scotland for the 63rd Congress of the European Renal Association (ERA).

From 3-5 June, you can meet us at booth no. 260 together with our partners from Kimal.

We’ve got more than one solution to prevent catheter-related complications in haemodialysis ‒ and are happy to tell you all about it.

Now this just made our day. 👏While at the INSIGHTS IF conference, we had the chance to meet a very special visitor: Maïw...
18/05/2026

Now this just made our day. 👏

While at the INSIGHTS IF conference, we had the chance to meet a very special visitor: Maïwenn lives with parenteral nutrition and has been using TauroLock™ for five years.

Zero catheter-related complications so far.

Way to go, Maïwenn! We wish you ALL the best, keep shining bright! ☀️

PICC lines are a convenient and safe option for many patients ‒ from oncology and parenteral nutrition to ICU. As any va...
14/05/2026

PICC lines are a convenient and safe option for many patients ‒ from oncology and parenteral nutrition to ICU.

As any vascular-access device, they must be handled with utmost caution.

What are the dos and don'ts to avoid complications? What do experts recommend for locking and flushing?

Our latest article outlines the most important aspects of PICC-line management for patients and caregivers.

Link in comments!

Delighted to welcome our partner from Pharma Solutions at our headquarters. He got a thorough overview of research on ta...
07/05/2026

Delighted to welcome our partner from Pharma Solutions at our headquarters.

He got a thorough overview of research on taurolidine-based lock solutions... and the Würzburg Residence.

Now we're ready to make “the best solution down the line” available to even more patients in Oman!

05/05/2026

PICC lines are becoming more and more popular, for good reason. As an alternative to ports and CVCs, they can provide a safe and reliable venous access for months on end. But as any other vascular access device, they also carry the risk of biofilm, infection, and occlusion. (1,2) That’s why they should be locked and flushed on a regular basis.
Experts recommend the pulsatile flushing (or “push-pause”) technique: Intermittent flushing with 10 bolus doses of 1 ml each and a time interval of 0.4 seconds between two bolus doses, as demonstrated in this video. (3,4)

1) Chong et al. J Paediatr Child Health 2020. DOI: 10.1111/jpc.14506
2) Lauverjat et al. Clin Nutr 2017. DOI: 10.1016/S0261-5614(17)30669-6
3) Nickel et al. J Infus Nurs 2024. DOI: 10.1097/NAN.0000000000000532
4) Goossens. Nurs Res Pract 2015:2015:985686. DOI: 10.1155/2015/985686

Save the date: We would like to invite you to join our industry symposium at the INSIGHTS IF conference in Paris!  “𝘛𝘢𝘶𝘳...
30/04/2026

Save the date: We would like to invite you to join our industry symposium at the INSIGHTS IF conference in Paris!

“𝘛𝘢𝘶𝘳𝘰𝘭𝘪𝘥𝘪𝘯𝘦: 𝘛𝘩𝘦 𝘚𝘪𝘭𝘷𝘦𝘳 𝘉𝘶𝘭𝘭𝘦𝘵 𝘈𝘨𝘢𝘪𝘯𝘴𝘵 𝘊𝘢𝘵𝘩𝘦𝘵𝘦𝘳-𝘙𝘦𝘭𝘢𝘵𝘦𝘥 𝘐𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘯𝘴”

18 May, 02:45-03:45 pm CET at the Novotel Paris Centre Tour Eiffel.

Jakub Víšek, MD, Ph.D. and Dr. Samford Wong will share their insights on taurolidine-based lock solutions – how they can accelerate progress by reducing morbidity, mortality, and healthcare costs.

You can meet our team at booth no. 11 (Foyer Seine) throughout the conference, 17-18 May.

Adresse

August-Bebel-Str. 51
Waldbüttelbrunn
97297

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TauroPharm erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen